Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
19studies shown
Showing 1-12 of 19
Drug study icon
CompletedNCT00931723

Adult Bipolar Mania

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Belgium, Bulgaria, Germany, ...
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
Not recruitingEUCTR 2010-023992-24

International randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Belgium, Germany, Hungary, ...
Sponsor
University of Leipzig
Condition
Bipolarity
Other study type icon
CompletedNCT00888264

A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Belgium
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2008-007190-20

An International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR™ (Quetiapine Fumarate) i...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Belgium, Bulgaria, Germany
Sponsor
AstraZeneca AB
Condition
Bipolarity
Other study type icon
CompletedNCT01062607

the Clinical Management of Bipolar Disease

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalOver 18 Years
Countries
France, Belgium, Austria, ...
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2005-005345-19

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood S...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Belgium, Estonia
Sponsor
Janssen-Cilag International N.V.
Condition
Bipolarity
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In Belgium
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2005-005011-25

Open study of BF 2.649 in association with a mood stabilizer in depressed bipolar patients

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Belgium
Sponsor
BIOPROJET
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01050582

Safety study of safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Schizophrenia

This study is completed in the United States, in Belgium, in Germany, .... It is testing safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation for Schizophrenia.

In Belgium
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrugFrom 8 Years to 16 Years
Countries
United States, Belgium, Germany, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.